WEgovy Real World Assessment of Weight Loss in Korea

NCT07280221 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Semaglutide

Sponsor

Novo Nordisk A/S